BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 7042840)

  • 1. Modulation of lymphocyte migration by human lymphokines. I. Identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated mononuclear cells.
    Center DM; Cruikshank W
    J Immunol; 1982 Jun; 128(6):2563-8. PubMed ID: 7042840
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional characteristics of histamine receptor-bearing mononuclear cells. I. Selective production of lymphocyte chemoattractant lymphokines with histamine used as a ligand.
    Center DM; Cruikshank WW; Berman JS; Beer DJ
    J Immunol; 1983 Oct; 131(4):1854-9. PubMed ID: 6352807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombocyte migration inhibitory activity of concanavalin-A-stimulated human lymphocytes. In vivo and in vitro modifications by dipyridamole and acetylsalicylic acid.
    Coeugniet E
    Thromb Res; 1979; 15(3-4):297-307. PubMed ID: 386557
    [No Abstract]   [Full Text] [Related]  

  • 4. [Stimulation of human and bovine lymphocytes by various Streptococcus species].
    Hahn G; Heide P; Gross WL
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Sep; 255(2-3):214-20. PubMed ID: 6359774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of lymphocyte migration inhibition (LyMIF) and stimulatory (LyMSF) factors by T and B lymphocytes from rabbit peripheral blood stimulated with concanavalin-A.
    Skopińska E; Lukasik R
    Bull Acad Pol Sci Biol; 1980; 27(9):701-7. PubMed ID: 7004593
    [No Abstract]   [Full Text] [Related]  

  • 6. Partial characterization of a lymphoid cell line (Reh) product with leukocyte inhibitory factor (LIF) activity.
    Rocklin RE; Blidy A; Butler J; Minowada J
    J Immunol; 1981 Aug; 127(2):534-9. PubMed ID: 7019325
    [No Abstract]   [Full Text] [Related]  

  • 7. Human lymphocytes produce both leukocyte migration inhibition (LIF) and stimulation (MStF) factors after mitogen, alloantigens or antigen activation.
    Favila-Castillo L; Méndez-Samperio P; Cortés-Castillo MA; Sánchez-Ortega A
    Rev Latinoam Microbiol; 1988; 30(2):111-5. PubMed ID: 3064229
    [No Abstract]   [Full Text] [Related]  

  • 8. Spontaneous production of lymphocyte migration inhibitory factor (sLyMIF) by T and B lymphocytes from peripheral rabbit blood.
    Skopińska E; Lukasik R
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):43-8. PubMed ID: 7025792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the release of colony-stimulating activity from mitogen-stimulated lymphocytes.
    Ruscetti FW; Chervenick PA
    J Immunol; 1975 May; 114(5):1513-7. PubMed ID: 1123545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of cell cycle to recovery of IL 2 activity from human mononuclear cells, human and mouse T cell lines.
    Stadler BM; Dougherty SF; Farrar JJ; Oppenheim JJ
    J Immunol; 1981 Nov; 127(5):1936-40. PubMed ID: 6975304
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphokines: mediators of delayed hypersensitivity.
    Rocklin RE
    Prog Clin Biol Res; 1981; 58():7-12. PubMed ID: 7022482
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential effect of interferon on the production on virus- and mitogen-induced leukocyte inhibitory factors in human leukocyte cultures.
    Dinh PN; Rosztóczy I; Béládi I; Tóth M
    Acta Virol; 1980 Dec; 24(6):427-32. PubMed ID: 6163345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characteristics of histamine receptor-bearing mononuclear cells. II. Identification and characterization of two histamine-induced human lymphokines that inhibit lymphocyte migration.
    Berman JS; McFadden RG; Cruikshank WW; Center DM; Beer DJ
    J Immunol; 1984 Sep; 133(3):1495-504. PubMed ID: 6379050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of suppressor activity mediated by concanavalin-A stimulated cells towards aspecific LIF production.
    Beatrice F; Poggio E; Morra B; Cavallo GP; Di Fortunato V; Bussi M; Vercellino M; Sartoris A; Cortesina G
    G Batteriol Virol Immunol; 1982; 75(1-6):16-24. PubMed ID: 6227515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation by adherent cells and irradiation of in vitro LIF production by Con-A stimulated mononuclear cells.
    Sandru G; Veraguth P
    Immunobiology; 1981; 159(4-5):419-31. PubMed ID: 7026420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro studies on the interaction of human monocytes and the monocyte locomotion inhibitory factor produced by E. histolytica.
    Kretschmer R; Castro EM; Arellano J; Pacheco MG
    Arch Invest Med (Mex); 1986; 17 Suppl 1():243-6. PubMed ID: 2884963
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of lymphocyte migration by human lymphokines. II. Purification of a lymphotactic factor (LCF).
    Cruikshank W; Center DM
    J Immunol; 1982 Jun; 128(6):2569-74. PubMed ID: 7042841
    [No Abstract]   [Full Text] [Related]  

  • 18. Modulation of lymphocyte migration by human lymphokines. III. Characterization of a lymphocyte migration inhibitory factor (LyMIF35K).
    McFadden RG; Cruikshank WW; Center DM
    Cell Immunol; 1984 Apr; 85(1):154-67. PubMed ID: 6370461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of migration inhibition factor (MIF) by purified human T cell subpopulations.
    Warrington RJ; Olivier SL; Sauder PJ; Rutherford WJ
    Clin Exp Immunol; 1981 May; 44(2):324-31. PubMed ID: 6458429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Production of the leukocyte inhibitory factor (LIF) by peripheral blood lymphocytes in vitro and LIF-like plasma activity in paraproteinemic patients].
    Puppo F; Corsini G; Mangini P; Armani U; Piana A
    Haematologica; 1984; 69(4):394-402. PubMed ID: 6437916
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.